Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2019, 28(2):87-93

Significance of selected new biomarkers in diagnosis of abdominal aortic aneurysm

Farkašová Ľ1, Rašiová M1, Špak Ľ2, Koščo M1, Petrášová D3, Hudák M1, Valočik G4
1 Klinika angiológie VÚSCH, a. s. a LF UPJŠ, Košice
2 Oddelenia invazívnej angiológie, Nemocnica Štefana Kukuru, Michalovce
3 Laboratória výskumných biomodelov LF UPJŠ, Košice
4 Klinika kardiológie VÚSCH, a. s. a LF UPJŠ, Košice, Slovenská republika

Aim: Abdominal aortic aneurysm (AAA) is a major cause of morbidity and mortality worldwide. It is generally accepted that risk factors and gene polymorphism of immunoregulatory genes, metalloproteinases and cytokines contribute to the formation of AAA. Our aim was to determine the concentrations of selected serum biomarkers in patients with AAA and in a control group without AAA and to determine the relationship of selected biomarkers with regards to the disease.

Methods: We evaluated selected types of novel serum biomarkers in AAA (insulin-like growth factor 1, peroxiredoxine, tenascin C, collagen IV and XVIII fragments) by ELISA in duplicate samples using commercially available kits. Serum samples were analyzed in 46 patients with AAA (mean age 71.45 ± 7.5 years) with documented abdominal aortic aneurysm with diameters above 30 mm and 35 controls without AAA (mean age 66.46 ± 10.1 years).

Results: AAA patients had a significantly increased collagen type XVIII concentration compared to a control group without AAA (60.23 ± 42.03 ng/ml vs. 35.0 ± 30.44 ng/ml; p = 0.004). Other biomarker concentrations did not differ significantly between groups. We identified three factors affecting the incidence of AAA: higher age, BMI, and collagen XVIII concentration, all those three factors significantly increased the risk of coincidence of AAA (p = 0.012; p = 0.05; p = 0.008). In our study, age was the only independent predictor increasing abdominal aortic aneurysm. The risk of AAA increases approximately by 7% with each year of patient life.

Conclusion: In the case of abdominal aortic aneurysm, basement-membrane components undergo structural alterations, particularly collagen IV and XVIII. Based on this preliminary analysis of a small number of subjects, patients with AAA had a significantly increased level of serum type XVIII collagen. Hope remains with the use of serum biomarkers which can be helpful in explaining the pathological processes of AAA existence and progression and allow early and targeted treatment of potentially at-risk patients.

Keywords: abdominal aortic aneurysm; biomarkers; risk factors

Published: February 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Farkašová Ľ, Rašiová M, Špak Ľ, Koščo M, Petrášová D, Hudák M, Valočik G. Significance of selected new biomarkers in diagnosis of abdominal aortic aneurysm. Cardiology Letters. 2019;28(2-3):87-93.
Download citation

References

  1. Fleming C, Whitelock EP, Beil TL, et al. Screening for abdominal aortic aneurysm: a best evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2005;142:203211. Go to original source...
  2. Powel JT, Brady AR. Detection, management, and prospects for the medical treatment of small abdominal aortic aneurysms. Arteriosclerosis Thrombosis and Vascular Biology 2004;24:241245. Go to original source...
  3. Heikkinen M, Salenius JP, Auvinen O. Ruptured abdominal aneurysm in a well defined geographic area. J Vasc Surg 2002;36:291-296. Go to original source...
  4. Shakibaie F, Hall JC, Norman PE. Indications for operative management of abdominal aortic aneurysms. ANZ J Surg 2004;74:470-476. Go to original source...
  5. Darling RC, Messina CR, Brewster DC, et al. Autopsy study of unoperated abdominal aortic aneurysms. The case for early resection. Circulation 1997;56:II161-164.
  6. Maďarič J, Tóth M, Balász T, et al. Aneuryzma abdominálnej aorty - perkutánne endovaskulárne riešenie. Vask med 2013; (Supl. S2):10-14.
  7. Vardulaki KA, Walker NM, Day NE, et al. Quantifying the risk of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg 2000; 87:195-200. Go to original source...
  8. Brady AR, Thompson SG, Fowkes FG, et al. Abdominal aortic aneurysm expansion: Risk factors and time intervals for survei­ llance. Circulation 2004;110:16 -21. Go to original source...
  9. Singh K, Bønaa KH, Jacobsen BK, et al. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: The Tromsø Study. Am J Epidemiol 2001;154:236-244. Go to original source...
  10. Choke E, Cockerill G, Wilson WR, et al. Review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 2005;30:227-244. Go to original source...
  11. Ferket BS, Grootenboer N, Colkesen EB, et al. Systematic review of guidelines on abdominal aortic aneurysm screening. J Vasc Surg 2012;55:1296-1304. Go to original source...
  12. Moris DN, Georgopoulos SE. Circulating biomarkers for abdominal aortic aneurysm: what did well earn in the last decade? Int Angiol 2013;32:266-280.
  13. Eberlová L, Tonar Z, Křížková V, et al. Morfologie a etiopatogeneze aneuryzmatu břišní aorty. Čas lék čes 2012;151:55-63.
  14. Lindholt JS, Vammen S, Fasting H, et al. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg2000;20:281-285. Go to original source...
  15. Lv BJ, Lindholt JS, Cheng X, et al. Plasma cathepsin S and cystatin C levels and risk of Abdominal Aortic Aneurysm: a randomized population-based study. PLoS One 2012;7:article e41813. Go to original source...
  16. Ormezzano O, Baguet JP, Thony F, et al. Amino-terminal propeptide of type III procollagen is associated with ascending aortic aneurysm growth rate. International Journal of Cardiology 2010;145:379-380. Go to original source...
  17. Muehling BM, Paintner N, et al. In vivo study on the expression pattern of resistin in patients with AAA. Vasc Endovascul Surg 2011;45:63-68. Go to original source...
  18. Třeška V, Topolčan O, Pecen L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med 2000;38:11611164. Go to original source...
  19. Lindholt JS, Martin-Ventura JL, Urbonavicius S, et al. Insulin-like growth factor I - a novel biomarker of Abdominal Aortic Aneurysms. Eur J Vasc Endovasc Surg 2011;42:560-562. Go to original source...
  20. Yeap BB, Chubb SAP, McCaul KA, et al. Associations of IGF1 and its bindings proteins with abdominal aortic aneurysm and aortic diameter in older men. European Journal of Endocrinology 2012;166:191-197. Go to original source...
  21. Moris D, Mantonakis E, Avgerinos E, et al. Novel biomarkers of abdominal aortic aneurysm disease: identifying gaps and dispelling misperceptions. Bio Med Research International 2014;20:925840. Go to original source...
  22. Kimura T, Shiraishi K, Furusho A, et al. Tenascin C protects aorta from acute dissection in mice. Sci Rep 2014;4:4051. Go to original source...
  23. Ramazani M, Lundin C, Sund M. Increased circulating levels of basement-membrane components in patients with Abdominal Aortic Aneurysms - A Pilot Study. Eur J Vasc Endovasc Surg 2011;42:484-487. Go to original source...
  24. Siu KL, Cai H. Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm. Am J Physiol Heart Circ Physiol. 2014;307:H1559-564. Go to original source...
  25. Martinez-Pinna R, Ramos-Mozo P, Madrigal-Matute J, et al. Identi­ fication of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol2011;31:935943. Go to original source...
  26. Norman PE, Powell JT. Site Specificity of aneurysmal disease. Circulation 2010;121:560-568. Go to original source...
  27. Takagi H, Sugimoto M, Kato T, et al. Postoperative incision hernia in patients with abdominal aortic aneurysm and aortoiliac occlusive disease: a systematic review. European Journal of Vascular and Endovascular Surgery 2007;33:177-181. Go to original source...
  28. Andreassen M, Raymond I, Kistorp C, et al. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur J Endocrinol 2009;160:25-31. Go to original source...
  29. Conti E, Carrozza C, Capoluongo E, et al. Insulin-like growth factor-1 as a vascular protective factor. Circulation 2004;110:2260-2265. Go to original source...
  30. Laughlin GA, Barrett-Connor E, Criqui MH, et al. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 2004;89:114-120. Go to original source...
  31. Juul A, Scheike T, Davidsen M, et al. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation. 2002;106: 939-944. Go to original source...
  32. Cotrufo M, De Santo L, Della Corte A, et al. Basal lamina structural alterations in human asymmetric aneurysmatic aorta. Eur J Histochem 2005;49:363e70. Go to original source...
  33. Sode BF, Nordestgaard BG, Gronbaek M, et al. Tobacco smoking and aortic aneurysm: two population-based studies. Int J Cardiol 2013;167:2271-2277. Go to original source...
  34. Sweeting MJ, Thompson SG, Brown LC, et al. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012;99:655-665. Go to original source...
  35. Lee WA, Brown MP, Nelson PR, et al. Total percutaneous access for endovascular aortic aneurysm repair (Preclose" technique). Vasc Surg 2007;45:1095-1101. Go to original source...
  36. Quinn SF, Kim J. Percutaneous femoral closure following stent-graft placement: use of the Perclose device. Cardiovasc Intervent Radiol 2004;27:231-236. Go to original source...
  37. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines; Trans Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463654. Go to original source...
  38. Cernohorsky P, Reijnen MM, Tielliu IF, et al. The relevance of aortic endograft prosthetic infection. J Vasc Surg 2011;54:327-33. Go to original source...
  39. Maleux G, Koolen M, Heve S, et al. Limb occlusion after endovascular repair of abdominal aortic aneurysms with supported endografts. 2008;19:1409-1412.
  40. Wang G, Zhai S, Li T, et al. Limb graft occlusion following endovascular aortic repair: Incidence, causes, treatment and prevention in a study cohort. Exp Ther Med 2017;14:1763-1768. Go to original source...
  41. Liaw JV, Clark M, Gibbs R, et al. Update: complications and management of infrarenal EVAR. Eur J Radiol 2009;71:541551. Go to original source...
  42. Maleux G, Koolen M, Heye S. Complications after endovascular aneurysm repair. Semin Intervent Radiol 2009;26:3-9. Go to original source...